ERCC1 as a predictor of response to induction therapy for stage III non-small cell lung cancer.

被引:0
|
作者
Marra, Alessandro
Kemming, Dirk
Krueer, Thomas
Bosse, Ulrich
Netchaeva, Maria
Wagner, Wolfgang
Koch, Olaf M.
Vogt, Ulf
Hillejan, Ludger
机构
[1] Niels Stensen Clin, Lung Ctr, Ostercappeln, Germany
[2] European Lab Assoc, Ibbenburen, Germany
[3] Inst Pathol Osnabruck, Osnabruck, Germany
[4] Klinikum Osnabruck, Osnabruck, Germany
[5] Paracelsus Klin, Dept Radiooncol, Osnabruck, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e18511
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients
    Park, So-Yeon
    Hong, Yun-Chul
    Kim, Jin-Hee
    Kwak, Seung-Min
    Cho, Jae-Hwa
    Lee, Hong-Lyeol
    Ryu, Jeong-Seon
    MEDICAL ONCOLOGY, 2006, 23 (04) : 489 - 498
  • [42] Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients
    So-Yeon Park
    Yun-Chul Hong
    Jin-Hee Kim
    Seung-Min Kwak
    Jae-Hwa Cho
    Hong-Lyeol Lee
    Jeong-Seon Ryu
    Medical Oncology, 2006, 23 : 489 - 498
  • [43] Synergistic effects of olaparib combined with ERCC1 on the sensitivity of cisplatin in non-small cell lung cancer
    Xie, Kejie
    Ni, Xiaoyan
    Lv, Shanmei
    Zhou, Guozhong
    He, Honger
    ONCOLOGY LETTERS, 2021, 21 (05)
  • [44] Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients
    Suk, R
    Gurubhagavatula, S
    Park, S
    Zhou, W
    Su, L
    Lynch, TJ
    Wain, JC
    Neuberg, D
    Liu, G
    Christiani, DC
    CLINICAL CANCER RESEARCH, 2005, 11 (04) : 1534 - 1538
  • [45] ERCC1 Expression in Non- Small Cell Lung and Esophageal Cancer
    Bilen, Nurhan
    Tekin, Salim B.
    Topdagi, Omer
    EURASIAN JOURNAL OF MEDICINE, 2014, 46 (02): : 84 - 88
  • [46] DNA repair by ERCC1 in non-small-cell lung cancer
    Cecere, Fabiana
    Bria, Emilio
    Rosell, Rafael
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (24): : 2590 - 2591
  • [47] A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with late-stage non-small cell lung cancer
    Jian Cheng
    Minwen Ha
    Yadi Wang
    Jing Sun
    Junchen Chen
    Yue Wang
    Chunyan Tong
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 231 - 238
  • [48] Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients
    Ryu, J
    Park, S
    Kwak, S
    Hong, Y
    Kim, J
    Cho, J
    Lee, H
    LUNG CANCER, 2005, 49 : S376 - S376
  • [49] A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with lat-stage non-small cell lung cancer
    Cheng, Jian
    Ha, Minwen
    Wang, Yadi
    Sun, Jing
    Chen, Junchen
    Wang, Yue
    Tong, Chunyan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (02) : 231 - 238
  • [50] Combined modality therapy for stage III non-small cell lung cancer
    Stinchcombe, Thomas E.
    Fried, Daniel
    Morris, David E.
    Socinski, Mark A.
    ONCOLOGIST, 2006, 11 (07): : 809 - 823